Canada markets closed

Malin Corporation plc (MLLNF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
5.45-2.15 (-28.29%)
At close: 03:18PM EDT

Malin Corporation plc

The Lennox Building
50 Richmond Street South
Dublin D02 FK02
Ireland
353 1 901 5700
https://www.malinplc.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. William F. DanielExecutive Chairman of the Board134.23kN/A1952
Ms. Fiona DunlevyCompany Secretary & Executive Director294.23kN/A1983
Andrea StaffordHead of FinanceN/AN/AN/A
Jessica BerginDirector of Investor Relations & External ReportingN/AN/AN/A
Dr. Andrew C. von Eschenbach M.D.Chief Medical AdviserN/AN/A1942
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also provides company secretarial services and engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

Corporate Governance

Malin Corporation plc’s ISS Governance QualityScore as of June 1, 2024 is 10. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.